IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.eu/fhir/ig/idea4rc/ValueSet/regimen-eu-i4rc | Version: 0.1.0 | |||
Draft as of 2025-07-25 | Computable Name: RegimenVS |
This ValueSet includes a curated list of chemotherapy regimens used in oncologic treatment protocols.
References
This value set includes codes based on the following rules:
http://fhir.ohdsi.org/CodeSystem/concepts
Code | Display |
35806965 | Doxorubicin and Ifosfamide |
35805248 | Ifosfamide and Paclitaxel |
35804228 | Epirubicin monotherapy |
35803691 | Etoposide monotherapy |
35804135 | Gemcitabine monotherapy |
35806435 | Ifosfamide and Gemcitabine |
35804542 | Ifosfamide monotherapy |
35805368 | Irinotecan liposomal monotherapy |
35805795 | Lenvatinib monotherapy |
35804095 | Methotrexate monotherapy |
35803677 | Nivolumab monotherapy |
35806821 | ADT (other androgen deprivation therapy) |
35805078 | Oxaliplatin monotherapy |
35804166 | Paclitaxel monotherapy |
35804158 | Gemcitabine and Paclitaxel |
35804201 | Paclitaxel and Trastuzumab (TH) |
35101452 | Paclitaxel and Vinorelbine |
35803678 | Pembrolizumab monotherapy |
35803487 | Sorafenib monotherapy |
35805230 | Trastuzumab emtansine monotherapy (TDM1) |
35804222 | Trastuzumab monotherapy |
35804241 | Vinorelbine monotherapy |
35806948 | Epirubicin and Ifosfamide |
35805452 | Vincristine, Actinomycin D, Ifosfamide (VAI) |
35803577 | Docetaxel and Gemcitabine |
35806964 | Dacarbazine and Doxorubicin |
35804819 | Cisplatin and Doxorubicin |
35805454 | Ifosfamide and Etoposide (IE) |
35806476 | Cyclophosphamide and Etoposide |
35806969 | Dacarbazine and Gemcitabine |
35805453 | Cyclophosphamide and Topotecan |
35805455 | Irinotecan and Temozolomide |
35804000 | Busulfan and Melphalan |
35805451 | Vincristine, Ifosfamide, Doxorubicin, Etoposide (VIDE) |
35805690 | Pazopanib monotherapy |
35804569 | Regorafenib monotherapy |
http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc
Code | Display |
2000100054 | doxorubicin and vincristine |
2000100055 | gemcitabine and vincristine |
2000100056 | high dose cisplatin |
2000100057 | ifosfamide and etoposide |
2000100058 | weekly carboplatin |
2000100059 | weekly cisplatin |
2000100060 | Vincristine and Doxorubicin and Ifosfamide |
2000100061 | Methotrexate and Doxorubicin and Cisplatin |
2000100062 | Methotrexate and Doxorubicin and Ifosfamide |
2000100063 | Doxorubicin and Cisplatin and Ifosfamide |
2000100064 | Methotrexate and Vinorelbine |
2000100065 | Vincristine and Doxorubicin and Cyclophosphamide |
2000100066 | Doxorubicin and Ifosfamide and Dacarbazine |
2000100067 | Irinotecan and Vincristine |
2000100068 | TNF and Melphalan |
2000100069 | Cyclophosphamide and Vinorelbine |
2000100070 | high dose Ifosfamide |
No Expansion for this valueset (Unknown Code System)
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |